Stryker Operating Income decreased by 48.1% to $936.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $837.00M to $936.00M. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 17.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher operating income indicates strong operational efficiency and pricing power, while a decline suggests rising costs or weakening demand.
Operating income is the profit realized from a company's core business operations after deducting all operating expenses...
A standard benchmark for operational performance; peers are compared based on operating margin percentages.
operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $732.00M | $574.00M | $819.00M | $447.00M | $772.00M | $808.00M | $814.00M | $735.00M | $965.00M | $931.00M | $1.26B | $972.00M | $1.05B | $1.09B | $581.00M | $837.00M | $1.11B | $1.14B | $1.80B | $936.00M |
| QoQ Change | — | -21.6% | +42.7% | -45.4% | +72.7% | +4.7% | +0.7% | -9.7% | +31.3% | -3.5% | +35.0% | -22.7% | +8.1% | +3.2% | -46.5% | +44.1% | +33.0% | +2.0% | +58.9% | -48.1% |
| YoY Change | — | — | — | — | +5.5% | +40.8% | -0.6% | +64.4% | +25.0% | +15.2% | +54.4% | +32.2% | +8.9% | +16.5% | -53.8% | -13.9% | +5.9% | +4.6% | +210.5% | +11.8% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| MedSurg and Neurotechnology: | $903.00M | $966.00M | $1.29B | $757.00M | $1.07B | $1.10B | $1.53B | $700.00M |
| Orthopaedics | — | — | $794.00M | $854.00M | — | — | — | — |
| Orthopaedics and Spine: | $676.00M | $643.00M | — | — | — | — | — | — |
| Total | $1.05B | $1.09B | $581.00M | $837.00M | $1.11B | $1.14B | $1.80B | $936.00M |
Orthopaedics and Spine: was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.